Thermo Fisher Scientific Inc Revenue 2007–2025
Thermo Fisher Scientific Inc reported $44.56B of revenue for fiscal 2025. That was 3.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +38.3%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $44.56B | +3.9% |
| FY 2024 | $42.88B | +0.1% |
| FY 2023 | $42.86B | -4.6% |
| FY 2022 | $44.91B | +14.5% |
| FY 2021 | $39.21B | +21.7% |
| FY 2020 | $32.22B | +26.1% |
| FY 2019 | $25.54B | +4.9% |
| FY 2018 | $24.36B | +16.4% |
| FY 2017 | $20.92B | +14.5% |
| FY 2016 | $18.27B | +7.7% |
| FY 2015 | $16.96B | +0.4% |
| FY 2014 | $16.89B | +29.0% |
| FY 2013 | $13.09B | +4.6% |
| FY 2012 | $12.51B | +8.2% |
| FY 2011 | $11.56B | +11.2% |
| FY 2010 | $10.39B | +4.9% |
| FY 2009 | $9.91B | -5.6% |
| FY 2008 | $10.50B | +7.7% |
| FY 2007 | $9.75B | — |
Source: Thermo Fisher Scientific Inc SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TMO 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Thermo Fisher Scientific Inc reported $44.56B of revenue for fiscal 2025. That was 3.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +38.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Thermo Fisher Scientific Inc
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeThermo Fisher Scientific Inc — frequently asked questions
What is Thermo Fisher Scientific Inc's revenue?
Thermo Fisher Scientific Inc (TMO) reported revenue of $44.56B for fiscal year 2025, per its SEC filings.
How has Thermo Fisher Scientific Inc's revenue changed over time?
Between fiscal 2007 and 2025, TMO's revenue grew at roughly 8.8% per year (compound annual rate), from $9.75B to $44.56B.
Where does this data come from?
Figures are computed from Thermo Fisher Scientific Inc's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.